Delivery Order SPE2DB22D2206-SPE2DB25FKB57
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,900.38 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of ZYNRELEF 400-12 mg/14 mL vials. ZYNRELEF is a liposomal bupivacaine and meloxicam combination product used for postsurgical pain management. The contract represents a firm fixed price delivery order with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a $5,127.41 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for ZYNRELEF 400-12 mg/14 ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded. ZYNRELEF is a liposomal bupivacaine and meloxicam combination product used for local...
- The Defense Logistics Agency awarded a $9,522 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of ZYNRELEF 200-6 mg/7 ml vials. This non-competitive, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ZYNRELEF 200-6 MG/7 ML VIAL 7ML pharmaceutical product, with a ceiling value of $1,744.77. The contract is a firm fixed-price delivery order with a completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Department's Medical Supply Chain awarded a $9,287.25 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, a specialty pharmaceutical product used in pain management. This firm fixed-price, competitively awarded contract was executed on September 3, 2025, with completion scheduled for September 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pen (2-pack units) on August 5, 2025, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,007.12 for Zymfentra 120 mg/ml pens (2-pack quantity) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively through the federal procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, valued at $1,485.96 with a firm fixed price structure. The contract, awarded on August 13, 2025, carries an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order falls...